Antimicrobial susceptibility of uropathogens and outcome following antibiotic treatment for urinary tract infections in primary health care;Sensibilidad antimicrobiana de los uropatógenos y resultados del tratamiento antibiótico de las infecciones urinarias en atención primaria

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 24, Issue 7, 2006, Pages 418-425

  Vallano, Antonio ^a,d   Rodríguez, Dolores ^a   Barceló, Ma Estrella ^b,c   López, Anna ^b,c   Cano, Ángel ^b,c   Viñado, Belén ^b   Diogene, Eduard ^a  

^a Fundacion Institut Catala de Farmacologia   (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

^c MEDICINA FAMILIAR Y COMUNITARIA   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Antimicrobial agents; Bacteria; Drug resistance; Outcome assessment; Primary health care; Treatment outcome; Urinary tract infections

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFUROXIME AXETIL; FOSFOMYCIN; NORFLOXACIN; PIPEMIDIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROMETAMOL;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINE CULTURE;

EID: 33749377215     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13091778     Document Type: Article

References (29)

1. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328-34.
2. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49:53-70.
3. Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J. Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997. Antoine Van Leeuwenhoek. 2000;77:147-52.
4. Gupta K, Scholes D, Staman W. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999;281:736-8.
5. Anandkumar H, Kapur I, Dayanand A. Increasing prevalence of antibiotic-resistance and multi drug resistance among uropathogens. J Commun Dis. 2003;35:102-8.
6. Kahlmeter G. The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report. J Antimicrob Chemother. 2000;46 Suppl 1:15-22.
7. Kahlmeter G. ECO.SENS. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother. 2003;51:69-76.
8. Bjornson D, Rovers J, Burian J, Hall N. Pharmacoepidemiology of urinary tract infections in Iowa Medicaid patients in urban long-term-care facilities. Ann Pharmacother. 1997;31:837-41.
9. Hummers-Pradier E, Kochen MM. Urinary tract infections in adult general practice patients. Br J Gen Pract. 2002;52:752-61.
10. Naber KG. Treatment options for acute uncomplicated cystitis in adults. J Antimicrob Chemother. 2000;46 Suppl 1:23-7.
11. Larcombe J. Urinary tract infection. Clin Evid. 2002;8:406-20.
12. Warren JW, Abrutyn E, Hebel R, Johnson R, Shaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis. 1999;29:745-58.
13. Mur T, Jorba E, Díez Caballero M. Estudio de la infección urinaria en un área de Terrassa. Aten Primaria. 2002;30:333-4.
14. Hu KK, Boyko EJ, Scholes D, Normand E, Chen CL, Grafton J, et al. Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med. 2004;164:989-93.
15. Boyko EJ, Fihn SD, Scholes D, Chen CL, Normand EH, Yarbro P. Diabetes and the risk of acute urinary tract infection among postmenopausal women. Diabetes Care. 2002;25:1778-83.
16. Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am. 1995;9:25-51.
17. Baerheim A, Digranes A, Hunskaar S. Are resistance patterns in uropathogens published by microbiological laboratories valid for general practice? APMIS. 1999;107:676-80.
18. Davey P, Steinke D, MacDonald T, Phillips G, Sullivan F. Not so simple cystitis: how should prescribers be supported to make informed decisions about the increasing prevalence of infections caused by drug-resistant bacteria? Br J Gen Pract. 2000;50:143-6.
19. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001;135:41-50.
20. Miller LG, Tang AW. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance. Mayo Clin Proc. 2004;79:1048-53.
21. Nicolle LE, Hoepelman AI, Floor M, Verhoef J, Norgard K. Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection. Scand J Infect Dis. 1993;25:631-7.
22. McCarty JM, Richard G, Huck W, Tucker RM, Tosiello RL, Shan M, et al. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am J Med. 1999;106:292-9.
23. Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ. The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand J Infect Dis. 2004;36:296-301.
24. Andreu A, Alós JI, Gobernado M, Marco F, De la Rosa M, García-Rodríguez JA; Grupo Cooperativo Español para el Estudio de la Sensibilidad Antimicrobiana de los Patogenos Urinarios. Etiología y sensibilidad a los antimicrobianos de los uropatógenos causantes de la infección urinaria baja adquirida en la comunidad. Estudio nacional multicéntrico. Enferm Infecc Microbiol Clin. 2005;23: 4-9.
25. Atienza Morales MP, Castellote Varona FJ, Romero Portilla C. Infección urinaria y sensibilidad antibiótica en el sur de la provincia de Albacete. An Med Interna. 1999;16:236-8.
26. Rabanaque Mallén G, García Domingo C, Escoms Tullenque R. ¿Existen las mismas resistencias de uropatógenos a antibióticos en los ámbitos de la atención primaria y hospitalario? Aten Primaria. 2004;33:285-7.
27. Alonso Sanz M, Abad Bécquer MI. Fenotipos de resistencia en aislamientos urinarios de Escherichia coli en la comunidad: implicaciones terapéuticas. Med Clin (Barc). 2003;120:361-4.
28. a ed. Recomendaciones en el uso de antimicrobianos en atención primaria. Barcelona: EdiDe; 1999. p. 40-61.
29. Mensa J, Pigrau C, Horcajada JC, Cartón JA, Pujol M. IV Infección urinaria. En: Aguado JM, Almirante B, Fortún J, editores. Protocolos clínicos de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica [citado 10 mar 2005]; 1(1):[42 pantallas]. Disponible en: http://www.seimc.org/ protocolos/clinicos/index.htm